Mulligan, K <br/><br/>
Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Oct 1993 
 - 956-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jcem.77.4.8408471  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Blood Glucose--analysis<br/>Emaciation--drug therapy<br/>Energy Metabolism--drug effects<br/>Growth Hormone--pharmacology<br/>HIV Infections--complications<br/>Humans<br/>Insulin--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Lipids--blood<br/>Male<br/>Nitrogen--urine<br/>Oxidation-Reduction<br/>Potassium--blood<br/>Recombinant Proteins--pharmacology<br/>Sodium--blood<br/>Urea--urine<br/>Weight Loss--drug effects